These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 237416)

  • 41. Design of a filter train for precipitate removal in monoclonal antibody downstream processing.
    Kandula S; Babu S; Jin M; Shukla AA
    Biotechnol Appl Biochem; 2009 Oct; 54(3):149-55. PubMed ID: 19656082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line.
    Kintzel PE; Kennedy PE
    Am J Hosp Pharm; 1991 Feb; 48(2):283-5. PubMed ID: 2003501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biochemical shifts in the nuclear membranes of the kidneys of dogs after the prolonged intravenous administration of amphotericin B].
    Asinovskaia NK; Oksman AIa; Kravchenko LS; Tereshin IM
    Antibiotiki; 1978 Aug; 23(8):731-6. PubMed ID: 686698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.
    Sonavane G; Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2008 Oct; 66(2):274-80. PubMed ID: 18722754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous solution compatibility and filter-retention characteristics of trace-element preparations.
    Boddapati S; Yang K; Murty R
    Am J Hosp Pharm; 1981 Nov; 38(11):1731-6. PubMed ID: 6795924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double-blind evaluation of 5-mum final filtration to reduce postinfusion phlebitis.
    Evans WE; Barker LF; Simone JV
    Am J Hosp Pharm; 1976 Nov; 33(11):1160-3. PubMed ID: 998633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Particles in intravenous solutions: a review.
    Thomas WH; Lee YK
    N Z Med J; 1974 Aug; 80(522):170-8. PubMed ID: 4608302
    [No Abstract]   [Full Text] [Related]  

  • 48. Filtration of crushed tablet suspensions has potential to reduce infection incidence in people who inject drugs.
    Ng H; Patel RP; Bruno R; Latham R; Wanandy T; McLean S
    Drug Alcohol Rev; 2015 Jan; 34(1):67-73. PubMed ID: 25196921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deaggregation of nanodiamond powders using salt- and sugar-assisted milling.
    Pentecost A; Gour S; Mochalin V; Knoke I; Gogotsi Y
    ACS Appl Mater Interfaces; 2010 Nov; 2(11):3289-94. PubMed ID: 21043470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Filtration artifacts caused by overloading membrane filters.
    Morrison MA; Benoit G
    Environ Sci Technol; 2001 Sep; 35(18):3774-9. PubMed ID: 11783658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Particles shed from syringe filters and their effects on agitation-induced protein aggregation.
    Liu L; Randolph TW; Carpenter JF
    J Pharm Sci; 2012 Aug; 101(8):2952-9. PubMed ID: 22674153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol.
    Perez M; Décaudin B; Abou Chahla W; Nelken B; Storme L; Masse M; Barthélémy C; Lebuffe G; Odou P
    Sci Rep; 2018 May; 8(1):7714. PubMed ID: 29769547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Particle contamination of parenteralia and in-line filtration of proteinaceous drugs.
    Werner BP; Winter G
    Int J Pharm; 2015 Dec; 496(2):250-67. PubMed ID: 26556624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increasing parvovirus filter throughput of monoclonal antibodies using ion exchange membrane adsorptive pre-filtration.
    Brown A; Bechtel C; Bill J; Liu H; Liu J; McDonald D; Pai S; Radhamohan A; Renslow R; Thayer B; Yohe S; Dowd C
    Biotechnol Bioeng; 2010 Jul; 106(4):627-37. PubMed ID: 20229510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contamination control in nursing with filtration. Part 1: filters applied to intravenous fluids and point-of-use hospital water.
    Ortolano GA; Russell RL; Angelbeck JA; Schaffer J; Wenz B
    J Infus Nurs; 2004; 27(2):89-103. PubMed ID: 15085036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigations into the fouling mechanism of parvovirus filters during filtration of freeze-thawed mAb drug substance solutions.
    Barnard JG; Kahn D; Cetlin D; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Mar; 103(3):890-9. PubMed ID: 24549732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The retention of large particles (greater than 2mum) in fibrous filters.
    Stenhouse JT; Lloyd PJ; Buxton RE
    Am Ind Hyg Assoc J; 1976 Jul; 37(7):432-6. PubMed ID: 961602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of membrane filtration for removal of diminutive bioburden organisms in pharmaceutical products and processes.
    Sundaram S; Auriemma M; Howard G; Brandwein H; Leo F
    PDA J Pharm Sci Technol; 1999; 53(4):186-201. PubMed ID: 10754712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of different purification techniques on triamcinolone yield and particle size spectrum.
    Szurman P; Kaczmarek R; Jaissle GB; Grisanti S; Lüke M; Spitzer MS; Heide PE; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):689-96. PubMed ID: 17006679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Air sampling filtration media: Collection efficiency for respirable size-selective sampling.
    Soo JC; Monaghan K; Lee T; Kashon M; Harper M
    Aerosol Sci Technol; 2016 Jan; 50(1):76-87. PubMed ID: 26834310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.